【摘要】 淋病奈瑟球菌简称淋球菌(Neisseria gonorrhoeae,NG)耐药一直是淋病防治面临的一个重要难题。头孢曲松是目前治疗淋病的主要一线药物。但是,淋球菌对头孢曲松敏感性下降趋势很明显,而且中国少数地区淋球菌头孢曲松耐药株检出率大于5%,故应密切监测淋球菌对头孢曲松的敏感性变化。目前,国外已有头孢曲松临床治疗失败的报道。更多还原

【Abstract】 Neisseria gonorrhoeae drug resistance has been an important problem for gonorrhea prevention.Ceftriaxone is a first-line drug for the treatment of gonorrhea.Further more ceftriaxone resistance rates are above 5% in few areas of China.In view of the tendency of Neisseria gonorrhoeae less susceptibie to ceftriaxone,it is necessary to monitor ceftriaxone resistance to Neisseria gonorrhoeae.Nowadays the treatment failure on ceftriaxone has been reported in foreign countries.更多还原